MétaCan
Menu
← Back to cohort

A Treat to Target Approach Decreases the Rate of CD-Related Adverse Outcomes versus a Clinical Approach in Patients With Moderate to Severely Active Crohnʼs Disease: Data From CALM 2017 ACG Governors Award for Excellence in Clinical Research

2017· article· en· W2913205231 on OpenAlexaff
Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt, Filip Baert, Tomáš Vaňásek, Ahmet Danalıoğlu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hébuterne, Simon Travis, Silvio Danese, Walter Reinisch, William J. Sandborn, Paul Rutgeerts, Daniël W. Hommes, Stefan Schreiber, Ezequiel Neimark, Bidan Huang, Qian Zhou, Wan‐Ju Lee, Joel Petersson, Kori Wallace, Anne Robinson, Roopal Thakkar, Geert D’Haens

Bibliographic record

VenueThe American Journal of Gastroenterology · 2017
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsUniversity of Calgary
Fundersnot available
KeywordsMedicineHazard ratioAzathioprineInternal medicineClinical endpointGastroenterologyAdverse effectRandomizationCalprotectinAdalimumabCrohn's diseasePrednisoneRandomized controlled trialInflammatory bowel diseaseSurgeryConfidence intervalDisease

Abstract

fetched live from OpenAlex

Introduction: Superior endoscopic outcomes in patients (pts) with moderate to severe Crohn's disease (CD) were achieved with tight control (T2T) of inflammation using biomarkers (C-reactive protein [CRP] and fecal calprotectin [FC]) compared to standard clinical management (CM) in CALM1. Differences in hospitalizations and serious disease-related complications between the study arms were analyzed. Methods: Immunosuppressive and biologic-naïve adults with CD; baseline CDAI>150-450 (+/- corticosteroids [CS]), active endoscopic CD (overall CDEIS>6 and sum of CDEIS subscores >6 in ≥1 segment with ulcers), and CRP≥5 mg/L and/or FC≥250 ìg/g received prednisone burst/taper ≤8 weeks (wk), then randomized to T2T or CM at wk 9. Early randomization was allowed for some pts. Pts received ≤4 treatment options in a stepwise manner based on pre-defined success criteria: no treatment; 160/80 mg adalimumab (ADA) wks 0/2, 40 mg every other wk; ADA 40 mg wkly; ADA 40 mg wkly+azathioprine 2.5 mg/kg/day. CD-related hospitalizations, CD-related surgical procedures (major and non-major) and a composite endpoint of CD-related hospitalization or serious complication from randomization up to wk 48, were summarized as incidences or rates (events [E]/100 Patient Years [PY]). Chi-square test was used for differences between study arms. Hazard ratio (HR) of the composite endpoint was determined using Cox proportional hazard model. Any hospitalization was reported for all pts on or after randomization and up to 70 days after last dose. Results: A total of 244 pts were randomized 1:1 to T2T and CM. BL mean ± SD age was 31.6 ± 11.7 years and 57.8% were female. The rate of CD-related hospitalizations after randomization was significantly lower with T2T compared to CM (Table). The rate of CD-related surgical procedures and the proportion of pts with CD-related hospitalization or serious complication were numerically lower in T2T compared to CM (Table). The risk of CD-related hospitalization or serious complication was numerically lower with T2T than CM: HR=0.7, 95% CI 0.4-1.3, P=0.249.Table: No Caption availableConclusion: A T2T approach using tight control of inflammation by biomarkers leads to a reduction of major adverse outcomes indicative for a detrimental course of disease, including CD-related hospitalizations. A longer study is needed to confirm these findings.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.015

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.073
GPT teacher head0.387
Teacher spread0.314 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueThe American Journal of Gastroenterology→Same topicInflammatory Bowel Disease→French-language works237,207→